Celularity Announces Promising Phase 2 Results for Diabetic Foot Ulcer Treatment
A New Hope for Patients with Diabetic Foot Ulcers and Peripheral Artery Disease Do you or someone you know struggle with the healing of diabetic foot ulcers? The presence of peripheral artery disease (PAD) can make this condition even more challenging to treat. Celularity Inc. has announced encouraging results from a Phase 2 clinical trial […]
Cytora Stem Cell Trial Shows Promise for Diabetic Foot Ulcers
Cytora, a biopharmaceutical firm, announced positive outcomes from its Phase 1/2a trial concerning hOMSC200, a stem cell therapy for diabetic foot ulcers. The study indicated that the treatment, derived from oral mucosa stem cells, is safe and did not trigger immune responses in patients. Furthermore, hOMSC200 demonstrated superior effectiveness in healing these chronic wounds compared to […]